败血症引起的凝血病的生物标志物:诊断见解和潜在的治疗影响
Anaïs Curtiaud1,2, Toshiaki Iba3, Eduardo Angles-Cano4
1Faculté de Médecine, Service de Médecine Intensive-Réanimation, Université de Strasbourg (UNISTRA), Hôpitaux universitaires de Strasbourg, Nouvel Hôpital Civil, 1, place de l'Hôpital, Strasbourg, F-67091, cedex, France.
Annals of intensive care
|January 17, 2025
概括
在重症患者中诊断出败血症诱导的凝血病 (SIC) 和扩散性血管内凝血 (DIC) 是很困难的. 本综述检查了改善诊断的生物标志物,并评估了抗凝剂治疗的有效性.
科学领域:
- 关键护理医学 关键护理医学
- 血液学 血液学 血液学
- 病理生理学 病理生理学
背景情况:
- 在败血症患者中诊断凝血病是具有挑战性的,因为复杂的病理生理学.
- 分布式血管内凝血 (DIC) 在败血症中具有很高的患病率和死亡率 (高达60%).
- 当前的诊断工具往往缺乏早期和准确的检测能力.
研究的目的:
- 评估传统和新兴的生物标志物来诊断败血症引起的凝血病 (SIC) 和DIC.
- 评估当前诊断生物标志物的局限性.
- 以生物标志物标准为指导,审查抗凝治疗的有效性.
主要方法:
- 对SIC和DIC的诊断生物标志物的系统文献综述.
- 评估传统的凝血测试 (例如,PT,aPTT,血小板计数,纤维素原).
- 评估新出现的生物标志物 (例如,D-二次体,可溶性血栓模块素,血栓-抗血栓复合物).
主要成果:
- 传统的生物标志物在早期和准确的SIC/DIC检测方面存在局限性.
- 新兴生物标志物显示出改善诊断灵敏度和特异性的前景.
- 以生物标志物标准为指导的抗凝药疗法需要进一步研究以获得最佳结果.
结论:
- 对于SIC和DIC,需要改进的诊断策略,包括新的生物标志物.
- 早期和准确的诊断对于及时干预和改善患者存活率至关重要.
- 需要进一步的研究来验证新出现的生物标志物,并完善治疗方法.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
606
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
606
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
96
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
55
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
55